A major advance in cancer study is arising with the use of mini-antibodies to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently inactivated in many types of tumors, resulting https://socialwoot.com/story23902242/mini-antibodies-revive-p53-a-promising-pathway-for-malignant-therapy